Skip to main content

Chesley Taft & Associates LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1164632 CHICAGO, IL

Position in REGN

as of Jun 30, 2026 · filed Jul 8, 2026
Position Value
$273,734
-$63,909 QoQ
Shares Held
439
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#965
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 5% Shared 0% None 95%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Chesley Taft & Associates LLC holds $811,194 across 2 Biotechnology names. REGN ranks #2 (33.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
439 $273,734

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273,734 439
2026-03-31 $337,643 437
2025-12-31 $954,803 1,237
2025-09-30 $244,587 435
2025-06-30 $228,375 435
2025-03-31 $307,601 485
2024-12-31 $345,480 485
2024-09-30 $509,851 485
2024-06-30 $509,749 485
2024-03-31 $466,807 485
2023-12-31 $425,970 485
2023-09-30 $399,135 485
2023-06-30 $348,491 485
2023-03-31 $398,509 485
2022-12-31 $349,922 485
2022-09-30 $334,101 485
2022-06-30 $626,006 1,059
2022-03-31 $718,674 1,029
2021-12-31 $649,834 1,029
2021-09-30 $558,581 923
2021-06-30 $515,532 923
2021-03-31 $462,730 978
2020-12-31 $566,688 1,173
2020-09-30 $656,621 1,173
2020-06-30 $918,636 1,473
2020-03-31 $719,251 1,473